Juan Ji
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Rapid intraoperative cytokeratin immunohistochemistry improves diagnostic accuracy of sentinel lymph nodes in post-neoadjuvant breast cancer.
Journal: Virchows Archiv : an international journal of pathology
Published: August 15, 2025
Artificial intelligence-assisted HER2 interpretation for breast cancers in a multi-laboratory study.
Artificial intelligence-assisted HER2 interpretation for breast cancers in a multi-laboratory study.
Journal: Gland surgery
Published: December 25, 2024
Infiltration and subtype analysis of CD3 + CD20 + T cells in lung cancer.
Journal: BMC cancer
Published: September 17, 2024
Differences in axillary response and treatment implications in HER2 positive node positive breast cancer during neoadjuvant HER2 targeted dual therapy.
Journal: Scientific reports
Published: July 22, 2024
Development of a prediction model for HER2 low breast cancer using quantitative intra- and peri-tumoral heterogeneity and MRI features on high-spatial resolution ultrafast DCE-MRI.
Journal: Quantitative imaging in medicine and surgery
Published: May 13, 2024
Genomic characteristics and evolution of Multicentric Esophageal and gastric Cardiac Cancer.
Journal: Biology direct
Published: April 30, 2024
Convenient determination of serum HER-2 status in breast cancer patients using Raman spectroscopy.
Journal: Journal of biophotonics
Published: July 24, 2023
Analysis of the Correlation and Prognostic Significance of Tertiary Lymphoid Structures in Breast Cancer: A Radiomics-Clinical Integration Approach.
Journal: Journal of magnetic resonance imaging : JMRI
Published: March 07, 2023
Clinicopathological features of rhabdomyosarcoma with novel FET::TFCP2 and TIMP3::ALK fusion: report of two cases and literature review.
Journal: Histopathology
Published: September 10, 2022
Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy.
Journal: Breast cancer research and treatment
Published: February 29, 2020
Last Updated: 09/26/2026